Tesla
TSLA
NVIDIA
NVDA
Alibaba
BABA
4
Palantir
PLTR
5
XPeng
XPEV
US Stock MarketDetailed Quotes
TVGN Tevogen Bio Holdings
- 1.035
- -0.025-2.36%
Trading Mar 11 12:17 ET
181.18MMarket Cap-12.94P/E (TTM)
1.090High1.030Low132.74KVolume1.060Open1.060Pre Close140.99KTurnover1.00%Turnover RatioLossP/E (Static)175.05MShares6.25052wk High-13.99P/B13.72MFloat Cap0.25652wk Low--Dividend TTM13.26MShs Float21.090Historical High--Div YieldTTM5.65%Amplitude0.256Historical Low1.062Avg Price1Lot Size
About Tevogen Bio Holdings Company
Tevogen Bio Holdings, Inc. is a clinical-stage specialty immunotherapy company. It develops off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company was founded on February 14, 2024 and is headquartered in Warren, NJ.
Company Profile
SymbolTVGN
Company NameTevogen Bio Holdings
Listing DateJan 3, 2022
CEODr. Ryan Saadi, M.D.,M.P.H.
MarketNASDAQ
Employees17
Fiscal Year Ends12-31
Address15 Independence Boulevard,Suite 410
CityWarren
ProvinceNew Jersey
CountryUnited States of America
Zip Code07059
Phone1-877-838-6436
Websitehttps://www.tevogen.com
Company Executives
- Name
- Position
- Salary
- Dr. Ryan Saadi, M.D.,M.P.H.
- Chairman of the Board and Chief Executive Officer
- 501.00K
- Dr. Neal Flomenberg, M.D.
- Chief Scientific Officer and Global Research and Development Lead
- 2.93M
- Sadiq Khan
- Chief Commercial Officer
- --
- Kirti Desai
- Chief Financial Officer
- 300.00K
- Jeffrey Feike
- Director
- --
- Dr. Curtis Patton
- Director
- --
- Susan M. Podlogar
- Director
- --
- Victor Sordillo
- Director
- 253.46K
- Dr. Keow Lin Goh
- Director
- --